Mitchell & Pahl Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Mitchell & Pahl Private Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.05M	Hold	2,009	–	–	0.38%	90
2026 Q2	$998K	Hold	2,009	–	–	0.37%	91
2026 Q1	$897K	Sell	2,009 -40	-2%	-$18.7K	0.36%	96
2025 Q4	$929K	Sell	2,049 -95	-4%	-$40.9K	0.39%	93
2025 Q3	$840K	Hold	2,144	–	–	0.35%	100
2025 Q2	$955K	Sell	2,144 -5	-0.2%	-$2.3K	0.42%	82
2025 Q1	$1.04M	Hold	2,149	–	–	0.49%	74
2024 Q4	$865K	Sell	2,149 -30	-1%	-$13.9K	0.4%	87
2024 Q3	$1.01M	Sell	2,179 -4	-0.2%	-$1.92K	0.47%	82
2024 Q2	$1.02M	Sell	2,183 -29	-1%	-$12.6K	0.54%	74
2024 Q1	$925K	Sell	2,212 -5	-0.2%	-$2.11K	0.49%	75
2023 Q4	$902K	Sell	2,217 -13	-0.6%	-$4.8K	0.51%	73
2023 Q3	$775K	Sell	2,230 -42	-2%	-$14.7K	0.46%	78
2023 Q2	$800K	Sell	2,272 -1	-0%	-$337	0.48%	73
2023 Q1	$716K	Sell	2,273 -8	-0.4%	-$2.4K	0.45%	81
2022 Q4	$659K	Sell	2,281 -288	-11%	-$87.8K	0.43%	83
2022 Q3	$744K	Sell	2,569 -53	-2%	-$15.2K	0.55%	69
2022 Q2	$739K	Sell	2,622 -155	-6%	-$41.5K	0.51%	74
2022 Q1	$725K	Sell	2,777 -28	-1%	-$6.64K	0.46%	78
2021 Q4	$616K	Sell	2,805 -262	-9%	-$50.9K	0.39%	85
2021 Q3	$556K	Sell	3,067 -20	-0.6%	-$3.9K	0.4%	82
2021 Q2	$622K	Sell	3,087 -9	-0.3%	-$1.88K	0.44%	78
2021 Q1	$665K	Sell	3,096 -13	-0.4%	-$2.86K	0.52%	69
2020 Q4	$735K	Buy	+3,109	New	+$713K	0.62%	53

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Mitchell & Pahl Private Wealth's VRTX Position: Q3 2026 in Review

Mitchell & Pahl Private Wealth held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 2,009 shares worth $1.05M. The position accounts for 0.38% of the portfolio, ranked #90.

Mitchell & Pahl Private Wealth first reported a position in VRTX in Q4 2020 and has held it in 24 quarters since. 443 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Mitchell & Pahl Private Wealth held 2,009 shares of Vertex Pharmaceuticals worth $1.05M as of Q3 2026.
Mitchell & Pahl Private Wealth left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
Vertex Pharmaceuticals made up 0.38% of Mitchell & Pahl Private Wealth's portfolio in Q3 2026, its #90 holding.
Mitchell & Pahl Private Wealth first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
443 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q3 2026, filed 14 Oct 2026.